创伤性凝血病:20年后患病率与死亡关联持续存在
该回顾性队列研究纳入2018至2022年两家一级创伤中心≥18岁创伤患者20,107例,并与2003年里程碑数据比较,评估早期创伤性凝血病(eTIC)的患病率及其与死亡的关系。结果显示eTIC总体合并患病率为33.4%(凝血酶原时间异常者32%,部分凝血活酶时间异常者10%),全因死亡率为6.0%。凝血病在所有损伤严重度范围内均对死亡率有重大影响,损伤严重度评分越低影响越大;在多因素分析中,凝血病独立关联2.1倍死亡风险(95%CI 1.5-2.9),模型预测效能优异(AUROC 0.932)。结论认为,尽管创伤救治取得进展,eTIC相关生物标志物仍强烈预测不良结局。
要点
- 2018至2022年两家一级创伤中心≥18岁创伤患者中,eTIC总体合并患病率为33.4%(凝血酶原时间异常者32%,部分凝血活酶时间异常者10%)。
- 全因死亡率为6.0%,凝血病在所有损伤严重度范围内均对死亡率有重大影响,损伤严重度评分越低影响越大。
- 多因素分析显示,凝血病独立关联2.1倍死亡风险(95%CI 1.5-2.9),模型预测效能优异(AUROC 0.932)。
- 与2003年里程碑研究(eTIC患病率28%、死亡关联8.9%)相比,20年后eTIC患病率与死亡关联持续存在。
- 尽管创伤救治取得进展,与eTIC相关的凝血病生物标志物仍强烈预测不良结局。
适用人群与场景
- 2018至2022年两家一级创伤中心收治的≥18岁创伤患者,共20,107例;65%为男性,85%为钝性伤,平均年龄54±21岁,中位损伤严重度评分为10(10, 18),8%的患者到院时存在低血压。
诊断标准与关键阈值
- eTIC定义为凝血酶原时间异常(患病率32%)或部分凝血活酶时间异常(患病率10%),总体合并患病率为33.4%。
研究设计与关键结果
- 研究类型为回顾性队列研究,使用两家一级创伤中心前瞻性收集的数据,并与2003年数据比较;共纳入20,107例患者。
- eTIC总体合并患病率为33.4%(凝血酶原时间异常者32%,部分凝血活酶时间异常者10%),全因死亡率为6.0%。
- 凝血病在所有损伤严重度范围内均对死亡率有重大影响,损伤严重度评分越低影响越大。
- 在混合逻辑回归/分类与回归树分析中,凝血病独立关联2.1倍死亡风险(95%CI 1.5-2.9),模型预测效能优异(AUROC 0.932)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,尽管创伤救治取得进展,与eTIC相关的凝血病生物标志物仍强烈预测不良结局;凝血病在所有损伤严重度范围内均与死亡风险升高独立相关,且在损伤严重度评分较低时影响更大。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Introduction: A 2003 landmark study identified the prevalence of early trauma-induced coagulopathy (eTIC) at 28% with a strong association with mortality of 8.9%. Over the last 20 years, there have been significant advances in both the fundamental understanding of eTIC and therapeutic interventions. Methods: A retrospective cohort study was performed from 2018 to 2022 on patients ≥18 using prospectively collected data from two level 1 trauma centers and compared to data from 2003. Demographics, laboratory data, and clinical outcomes were obtained. Results: There were 20,107 patients meeting criteria: 65% male, 85% blunt, mean age 54 ± 21 years, median Injury Severity Score 10 (10, 18), 8% of patients were hypotensive on arrival, with an all-cause mortality 6.0%. The prevalence of eTIC remained high at 32% in patients with an abnormal prothrombin time and 10% with an abnormal partial thromboplastin time, for an overall combined prevalence of 33.4%. Coagulopathy had a major impact on mortality over all injury severity ranges, with the greatest impact with lower Injury Severity Score. In a hybrid logistic regression/Classification and Regression Trees analysis, coagulopathy was independently associated with a 2.1-fold increased risk of mortality (95% confidence interval 1.5-2.9); the predictive quality of the model was excellent [area under the receiver operating characteristic curve (AUROC) 0.932]. Conclusion: The presence of eTIC conferred a higher risk of death across all disease severities and was independently associated with a greater risk of death. Biomarkers of coagulopathy associated with eTIC remain strongly predictive of poor outcome despite advances in trauma care.
参考来源
- Teeter W, Neal MD, Brown JB, et al. TRAUMA-INDUCED COAGULOPATHY: PREVALENCE AND ASSOCIATION WITH MORTALITY PERSIST 20 YEARS LATER. Shock. 2024. PMID: 38920139. doi:10.1097/SHK.0000000000002416
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。